Extensively drug-resistant pseudomonas aeruginosa ST309 harboring tandem Guiana extended spectrum β-lactamase enzymes: a newly emerging threat in the united states

Treatment of serious infections due to multidrug-resistant (MDR) Pseudomonas aeruginosa remains a challenge, despite the introduction of novel therapeutics. In this study, we report 2 extensively drug-resistant clinical isolates of sequence type (ST) 309 P aeruginosa resistant to all β-lactams, incl...

Full description

Autores:

Tran, Truc T.
Rios, Rafael
Hanson, Blake
Shropshire, William C.
Sun, Zhizeng
Diaz, Lorena
Dinh, An Q.
Wanger, Audrey
Ostrosky-Zeichner, Luis
Palzkill, Timothy
Arias, Cesar A.
Miller, William R.

Tipo de recurso:

Article of journal

Fecha de publicación:

2019

Institución:

Universidad El Bosque

Repositorio:

Repositorio U. El Bosque

Idioma:

eng

OAI Identifier:

oai:repositorio.unbosque.edu.co:20.500.12495/5245

Acceso en línea:

http://hdl.handle.net/20.500.12495/5245
https://doi.org/10.1093/ofid/ofz273

Palabra clave:

GES beta-lactamase
Carbapenem-resistant Pseudomonas aeruginosa
Ceftolozane/tazobactam
Combination therapy

Rights

openAccess

License

Attribution-NonCommercial-NoDerivatives 4.0 International